Pharmaceutical (6)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE revokes the suspension in trading of equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to … | |||||||||||||||
BSE revokes the suspension in trading of equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to resume.
| |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to … | |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to resume.
| |||||||||||||||
BSE revokes the trading suspension on equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing trading to resume. | |||||||||||||||
BSE revokes the trading suspension on equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing trading to resume.
| |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to … | |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to resume.
| |||||||||||||||
NSE notifies the listing of Sudeep Pharma Limited equity shares with effect from November 28, 2025, following IPO at issue price of Rs. 593 … | |||||||||||||||
NSE notifies the listing of Sudeep Pharma Limited equity shares with effect from November 28, 2025, following IPO at issue price of Rs. 593 per share.
| |||||||||||||||
BSE announces listing of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective from August 26, 2025. | |||||||||||||||
BSE announces listing of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective from August 26, 2025.
| |||||||||||||||